Search results
Results: 218
Number of items: 218
-
Bots, C. P., Poorterman, J. H. G., Brand, H. S., Kalsbeek, H., van Amerongen, B. M., Veerman, E. C. I., & van Nieuw Amerongen, A. (2006). The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Diseases, 12, 176-180. https://doi.org/10.1111/j.1601-0825.2005.01183.x
-
Stallmann, H. P., Faber, C., Bronckers, A. L. J. J., van Nieuw Amerongen, A., & Wuisman, P. I. J. M. (2006). In vitro gentamicin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculosketal Disorders, 26, 7-18. https://doi.org/10.1186/1471-2474-7-18 -
Faber, C., Stallmann, H. P., Lyaruu, D. M., Joosten, U., von Eiff, C., van Nieuw Amerongen, A., & Wuisman, P. I. J. M. (2005). Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model. Antimicrobial Agents and Chemotherapy, 49, 2438-2444. https://doi.org/10.1128/AAC.49.6.2438-2444.2005
-
den Hertog, A. L., van Marle, J., van Veen, H. A., van 't Hof, W., Bolscher, J. G. M., Veerman, E. C. I., & van Nieuw Amerongen, A. (2005). Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochemical Journal, 388, 689-695. https://doi.org/10.1042/BJ20042099
-
van der Kraan, M. I. A., van Marle, J., Nazmi, K., Groenink, J., van 't Hof, W., Veerman, E. C. I., Bolscher, J. G. M., & van Nieuw Amerongen, A. (2005). Ultrastructural effects of antimicrobial peptides from bovine lactoferrin on the membranes of Candida albicans and Escherichia coli. A confocal and freeze-fracture electron microscopy study. Peptides, 26, 1537-1542. https://doi.org/10.1016/j.peptides.2005.02.011
Page 8 of 22